https://www.selleckchem.com/pr....oducts/alflutinib-as
In comparison to patients received combined ACLR and ALLR, patients who received isolated ACLR had a significantly lower negative pivot shift test rate (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.23 to 0.92, I = 0%, P= .03, 95% prediction interval [PrI] 1.00 to 2.26), Lysholm score (mean difference -2.79, 95 % CI -4.68 to -0.91, I = 77 %, P= .004, 95% PrI -10.81 to 5.42), Tegner score (mean difference -0.57, 95% CI -1.12 to -0.02, I = 90 %, P= .04, 95% PrI -3.12 to 1.93). Combined ALLR and ACLR could effect